TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q3 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $94,589,000 | +74.0% | 3,434,601 | +4.2% | 0.01% | +66.7% |
| Q1 2021 | $54,365,000 | -4.5% | 3,296,834 | +6.8% | 0.00% | 0.0% |
| Q4 2020 | $56,906,000 | -17.3% | 3,087,676 | -38.9% | 0.00% | -40.0% |
| Q3 2020 | $68,821,000 | +100.7% | 5,056,617 | +164.3% | 0.01% | +150.0% |
| Q2 2020 | $34,286,000 | +382.2% | 1,913,281 | +168.3% | 0.00% | +100.0% |
| Q1 2020 | $7,110,000 | +40.8% | 713,107 | +15.0% | 0.00% | – |
| Q4 2019 | $5,050,000 | -9.5% | 620,337 | +10.2% | 0.00% | – |
| Q3 2019 | $5,580,000 | -11.6% | 563,057 | +12.7% | 0.00% | – |
| Q2 2019 | $6,310,000 | +98.1% | 499,632 | +59.8% | 0.00% | – |
| Q1 2019 | $3,186,000 | +200.8% | 312,650 | +121.4% | 0.00% | – |
| Q4 2018 | $1,059,000 | +24.4% | 141,239 | +66.0% | 0.00% | – |
| Q3 2018 | $851,000 | – | 85,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |